Lymphocytic Esophagitis: A Case Series of Esophageal Disease with Increasing Frequency.

Autor:	Yousef M; Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Missouri, Columbia, Missouri, Mo, USA., Chela H; Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Missouri, Columbia, Missouri, Mo, USA., Ertugrul H; Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Missouri, Columbia, Missouri, Mo, USA., Albarrak A; Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Missouri, Columbia, Missouri, Mo, USA., Basar O; Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Missouri, Columbia, Missouri, Mo, USA., Pasha S; Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Missouri, Columbia, Missouri, Mo, USA., Mousa Y; Department of Pediatrics, Right Way (Germany) Heidekreis-Klinikum GmbH Krankenhaus Walsrode, Walsrode, Germany., Al Juboori A; Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Missouri, Columbia, Missouri, Mo, USA., Frazier S; Department of Pathology, University of Missouri, Columbia, Missouri, Mo, USA., Tahan V; Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Missouri, Columbia, Missouri, Mo, USA., Daglilar E; Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Missouri, Columbia, Missouri, Mo, USA.
Jazyk:	angličtina
Zdroj:	Recent advances in inflammation & allergy drug discovery [Recent Adv Inflamm Allergy Drug Discov] 2023; Vol. 17 (1), pp. 79-84.
DOI:	10.2174/2772270817666230130093341
Abstrakt:	Background: Lymphocytic esophagitis (LE) is a poorly understood clinical finding that has been increasingly identified in the last decade. Previous studies proposed increased frequency of LE in elderly females, as well as associations with smoking and pediatric Crohn's disease. Objective: We aimed to determine the patient characteristics and clinical features of our adult LE patients. As inflammation in the esophagus has been linked to cancer, this review also describes this association. However, there are no reported cases of malignant transformation in those with underlying lymphocytic esophagitis. Methods: We retrospectively reviewed records for patients at the University of Missouri Hospital- Columbia (located in the USA) who had a histopathological diagnosis of LE. Cases of LE were identified using the pathology reporting system at the University of Missouri Hospital for esophageal biopsy specimens for the above-mentioned period. Results: The data of a total of 20 adult cases with esophageal biopsy specimens consistent with LE were included. Conclusion: LE seems to be a benign but disturbing clinical problem and should be remembered in elderly females complaining of dysphagia or refractory reflux symptoms. It has similar endoscopic findings of eosinophilic esophagitis with rings and esophagitis. Smoking and hiatal hernia are common risk factors. The majority of LE patients can respond to proton pump inhibitor (PPI) therapy. Endoscopic dilations and steroid therapy should be considered for PPI nonresponder LE patients. (Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu